| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/17/1994 | WO1994001559A3 Dna sequences for an amino acid transporter, plasmids, bacteria, yeasts and plants containing a transporter and their use |
| 03/17/1994 | WO1993025682A3 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 03/17/1994 | WO1993018055A3 Peptides stimulating cytotoxic lymphocytes respone to hiv-1 gp160 |
| 03/17/1994 | DE4237430C1 Aufgereinigtes TSH-Präparat, Verfahren zu seiner Herstellung und seine Verwendung zur Herstellung von TSH-Tracern für TSH-Rezeptorassays und in TSH-Rezeptorassays Purified TSH preparation, process for its preparation and its use for the preparation of TSH tracers for TSH receptor assays and in TSH-receptor assays |
| 03/17/1994 | CA2144180A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | CA2143757A1 Method of preferential labelling of phycobiliprotein with amine-reactive dye for use in a multiple color assay |
| 03/17/1994 | CA2143748A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | CA2143739A1 Growth hormone potentiating molecules |
| 03/17/1994 | CA2143678A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 03/17/1994 | CA2143644A1 Products and methods for improving keratinocyte adhesion to the dermis |
| 03/17/1994 | CA2143611A1 Cloning and expression of pur protein |
| 03/17/1994 | CA2143299A1 Novel bacterial vaccines using vaccine strains of pathogenic bacteria |
| 03/17/1994 | CA2143188A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | CA2143007A1 Glucagon antagonists and methods for detecting glucagon antagonists |
| 03/17/1994 | CA2141935A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 03/17/1994 | CA2122912A1 Novel peptides, and platelet aggregation-inhibiting agents, blood coagulation-inhibiting agents for extracorporeal circulation, cell adhesion-inhibiting agents, tumor metastasis inhibiting agents, agents for protecting platelet preparations for blood transfusion and platelet preparation packs for transfusion using said novel peptides |
| 03/17/1994 | CA2122630A1 Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis |
| 03/16/1994 | EP0587541A1 Process to purify the big-endothelin protein |
| 03/16/1994 | EP0587427A1 Process for the production of human growth hormone |
| 03/16/1994 | EP0587298A2 Nucleic acid sequence amplification method |
| 03/16/1994 | EP0587279A1 Human nucleic acid fragments isolated from brain, adrenal tissue, placenta or bone narrow and their use |
| 03/16/1994 | EP0587255A1 Insulinotropic hormone |
| 03/16/1994 | EP0586892A1 Production of Bacillus Entomotoxins in Methylotrophic Yeast |
| 03/16/1994 | EP0586812A2 Medicaments comprising glicentin as active ingredient |
| 03/16/1994 | EP0586790A1 Amyloid precursor-like protein and uses thereof |
| 03/16/1994 | EP0586667A1 Refolding and purification of insulin-like growth factor i |
| 03/16/1994 | EP0586657A1 Receptor for the glucagon-like-peptide-1 (glp-1) |
| 03/16/1994 | EP0586618A1 The use of nucleic acid analogues in diagnostics and analytical procedures. |
| 03/16/1994 | EP0586607A1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2 |
| 03/16/1994 | EP0586596A1 Device and method for the analysis of rolling blood leukocytes and identifying inhibitors and promoters |
| 03/16/1994 | EP0586573A1 Endotoxin binding and neutralizing protein and uses thereof |
| 03/16/1994 | EP0586549A1 Selecting ligand agonists and antagonists |
| 03/16/1994 | EP0586537A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
| 03/16/1994 | EP0586505A1 Heteroconjugate antibodies for treatment of hiv infection |
| 03/16/1994 | EP0586474A1 Peptide nucleic acids |
| 03/16/1994 | EP0586465A1 Diagnostic peptides derived from m.tuberculosis antigens |
| 03/16/1994 | EP0586453A1 Stabilisation of plant extracts |
| 03/16/1994 | EP0586445A1 Monoclonal antibodies against c-kit |
| 03/16/1994 | EP0586381A1 Improved blood substitute |
| 03/16/1994 | EP0586372A1 RECOMBINANT 21 kD COCOA PROTEIN AND PRECURSOR |
| 03/16/1994 | EP0429624B1 RADIOIMMUNOTHERAPY USING $g(a)-PARTICLES EMISSION |
| 03/16/1994 | EP0413731B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 03/16/1994 | CA2107074A1 Application of peptide/cell receptor kinetics utilizing radiolabelled somatostatin congeners in the in situ, in vivo detection and differentiation of neoplastic tissue |
| 03/15/1994 | US5294700 Oligosaccharides from syncytiotrophoblast microvilli membranes |
| 03/15/1994 | US5294699 Absorbers |
| 03/15/1994 | US5294698 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| 03/15/1994 | US5294632 Diuretics and vasorelaxants |
| 03/15/1994 | US5294605 Antimicrobial, antitumor |
| 03/15/1994 | US5294569 Endothelin DNA and use thereof |
| 03/15/1994 | US5294551 Cell culture substrate coated with polypeptides having fibronectin activity |
| 03/15/1994 | US5294548 Baculovirus coding for the polyprotein in a infected host cell |
| 03/15/1994 | US5294544 Biologically active factor |
| 03/15/1994 | US5294543 Inhibitor of platelet aggregation |
| 03/15/1994 | US5294538 Enzyme inhibitor |
| 03/15/1994 | US5294536 Conjugates |
| 03/15/1994 | US5294533 Detection of food poisoning bacteria, bacterial meningitis |
| 03/15/1994 | US5294441 Immunization; obtained from a pathogenic S. typhi having the cya and crp genes deactivated by genetic mutation |
| 03/15/1994 | US5294430 Use of dithiocarbamates to treat myelosuppression |
| 03/15/1994 | CA1327866C Method for purifying and isolating carboxyl-terminal peptides |
| 03/15/1994 | CA1327762C Dna constructs containing a kluyveromyces alpha-factor leader sequence for directing secretion of heterologous polypeptides |
| 03/15/1994 | CA1327749C Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli |
| 03/10/1994 | DE4229876A1 Mistletoe lectin extn. - using a cationic ion exchanger for the isolation of MTLI-1 and MTL-1-2, MTLII and MTL-III, useful in bio-technology and diagnostics |
| 03/09/1994 | EP0586266A1 DNA fragments coding for the Neisseria meningitidis receptor fragments |
| 03/09/1994 | EP0586154A2 Melanin formation-inhibitory protein, and its preparation and uses |
| 03/09/1994 | EP0586094A1 Soluble LDL receptor and gene |
| 03/09/1994 | EP0586076A2 Recombinant adenovirus vaccines |
| 03/09/1994 | EP0586065A2 Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping using the same |
| 03/09/1994 | EP0586026A2 Characterization of a novel anti-p110 RB monoclonal antibody |
| 03/09/1994 | EP0585995A1 Pure human endothelial type plasminogen activator inhibitor (e-PAI) and production thereof |
| 03/09/1994 | EP0585987A1 Liquid thromboplastin reagent |
| 03/09/1994 | EP0585983A2 Nucleotide vector comprising a translation inhibition factor gene, and IRES region and a desired gene |
| 03/09/1994 | EP0585963A1 Monoclonal antibodies to CMP-170 antigen on activated endothelial cells |
| 03/09/1994 | EP0585960A2 Diagnostic method for autoimmune diseases |
| 03/09/1994 | EP0585957A1 Recombinant B-cell differentiation factor |
| 03/09/1994 | EP0585943A2 Soluble ligands for CD40 |
| 03/09/1994 | EP0585939A2 TNF ligands |
| 03/09/1994 | EP0585801A2 Bone-related cadherin-like protein and process for its production |
| 03/09/1994 | EP0585688A2 Aqueous dispersions of zein and controlled release coatings derived therefrom |
| 03/09/1994 | EP0585631A1 Platelet-increasing agent |
| 03/09/1994 | EP0585554A1 Process for preparing a transgenic plant expressing phytolacca antiviral protein |
| 03/09/1994 | EP0585549A2 Method for producing ectoprotein of hepatitis C virus |
| 03/09/1994 | EP0585520A1 Angiotensin II type-1 receptor and its production |
| 03/09/1994 | EP0585504A1 Phospholipid dependant prothrombin activator and its use in lupus anticoagulant testing |
| 03/09/1994 | EP0585444A1 Hepatoma treatment with somatostatin analogs |
| 03/09/1994 | EP0585415A1 Dna encoding a human 5-ht 1e? receptor and uses thereof |
| 03/09/1994 | EP0585399A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene |
| 03/09/1994 | EP0585398A1 Hcv genomic sequences for diagnostics and therapeutics |
| 03/09/1994 | EP0585396A1 NOVEL $i(BACILLUS THURINGIENSIS) ISOLATES ACTIVE AGAINST HYMENOPTERAN PESTS AND GENES ENCODING HYMENOPTERAN-ACTIVE TOXINS |
| 03/09/1994 | EP0585390A1 Stealth virus detection in the chronic fatigue syndrome |
| 03/09/1994 | EP0585384A1 Purification and cloning of p62 |
| 03/09/1994 | EP0585381A1 THE ASTROVIRUS HUMAN GASTROENTERITIS AGENTS AND MOLECULAR CLONING OF CORRESPONDING cDNAs |
| 03/09/1994 | EP0585375A1 Plant defense gene(s) and regulatory element(s) |
| 03/09/1994 | EP0585337A1 Method of suppressing tumor formation in vivo by administering je/mlp-1 |
| 03/09/1994 | EP0585310A1 Crosstalk inhibitors and their uses |
| 03/09/1994 | EP0585257A1 Dna and amino acid sequence specific for natural killer cells |
| 03/09/1994 | EP0585242A1 Wound healing |
| 03/09/1994 | EP0585216A1 Im peptides |
| 03/09/1994 | EP0585215A1 MUTANTS OR VARIANTS OF $i(BACILLUS THURINGIENSIS) PRODUCING HIGH YIELDS OF DELTA ENDOTOXIN |
| 03/09/1994 | EP0506789B1 Cloning vector for use in lactic acid bacteria and a method for constructing the same |
| 03/09/1994 | EP0437487B1 Targetting agents |